Distinguished in Calcium Pyrophosphate Arthritis

Florentin A. Vreju

2 Petru Rares Str, 
Craiova, DJ, RO 
Distinguished in Calcium Pyrophosphate Arthritis
2 Petru Rares Str, 
Craiova, DJ, RO 
OverviewLocationsClinical Research

Overview

Florentin Vreju practices in Craiova, Romania. Vreju is rated as a Distinguished expert by MediFind in the treatment of Calcium Pyrophosphate Arthritis. Their top areas of expertise are Arthritis, Osteoporosis, Calcium Pyrophosphate Arthritis, and Tendinitis.

Their clinical research consists of co-authoring 42 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Calcium Pyrophosphate Arthritis.

Locations

2 Petru Rares Str, Craiova, DJ 200349, Romania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

42 Total Publications

Tibial tuberosity maturation assessment by ultrasonography and screening for Osgood-Schlatter disease in male and female children and adolescent athletes: a cross-sectional study.
Tibial tuberosity maturation assessment by ultrasonography and screening for Osgood-Schlatter disease in male and female children and adolescent athletes: a cross-sectional study.
Journal: Research in sports medicine (Print)
Published: March 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Vreju's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile